BioCardia (BCDA) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free BCDA Stock Alerts $0.39 +0.01 (+2.60%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media BioCardia Short Interest DataCurrent Short Volume271,200 sharesPrevious Short Volume535,900 sharesChange Vs. Previous Month-49.39%Dollar Volume Sold Short$100,994.88Short Interest Ratio / Days to Cover0.8Last Record DateApril 15, 2024Outstanding Shares26,870,000 sharesPercentage of Shares Shorted1.01%Today's Trading Volume51,135 sharesAverage Trading Volume313,646 sharesToday's Volume Vs. Average16% Short Selling BioCardia ? Sign up to receive the latest short interest report for BioCardia and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBCDA Short Interest Over TimeBCDA Days to Cover Over TimeBCDA Percentage of Float Shorted Over Time Ad InvestorPlace$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details. BioCardia Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024271,200 shares $100,994.88 -49.4%N/A0.8 $0.37 3/31/2024535,900 shares $218,111.30 -46.9%N/A1.4 $0.41 3/15/20241,010,000 shares $393,900.00 +927.5%6.2%2.7 $0.39 2/29/202498,300 shares $54,065.00 -67.0%0.7%0.3 $0.55 2/15/2024297,600 shares $127,968.00 +84.2%2.5%1 $0.43 1/31/2024161,600 shares $73,237.12 +22.8%1.3%0.1 $0.45 Get the Latest News and Ratings for BCDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioCardia and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024131,600 shares $85,329.44 -39.2%1.1%0 $0.65 12/31/2023216,600 shares $143,865.72 -31.8%1.8%0.1 $0.66 12/15/2023317,800 shares $190,997.80 -9.0%2.7%0.1 $0.60 11/30/2023349,100 shares $216,860.92 +132.0%3.5%0.1 $0.62 11/15/2023150,500 shares $142,222.50 +13.4%1.5%0.1 $0.95 10/31/2023132,700 shares $49,404.21 -35.2%1.3%1.2 $0.37 10/15/2023204,900 shares $90,156.00 +9.8%2.1%1.5 $0.44 9/30/2023186,600 shares $80,219.34 +48.1%1.6%1.4 $0.43 9/15/2023126,000 shares $49,770.00 -36.7%1.1%0.9 $0.40 8/31/2023199,000 shares $155,220.00 +8.0%1.7%1.8 $0.78 8/15/2023184,300 shares $162,147.14 +575.1%1.5%1.9 $0.88 7/31/202327,300 shares $28,119.00 -84.0%0.2%0.3 $1.03 7/15/2023171,000 shares $398,430.00 -14.2%1.4%2.4 $2.33 6/30/2023199,400 shares $532,398.00 -4.3%1.6%5.1 $2.67 6/15/2023208,300 shares $477,007.00 +3.8%1.6%5.6 $2.29 5/31/2023200,600 shares $355,062.00 +1,443.1%1.6%6.9 $1.77 5/15/202313,000 shares $24,050.00 -29.4%0.1%0.5 $1.85 4/30/202318,400 shares $37,904.00 -12.0%0.1%0.9 $2.06 4/15/202320,900 shares $40,964.00 -23.7%0.1%0.9 $1.96 3/31/202327,400 shares $53,430.00 -26.9%0.2%1 $1.95 3/15/202337,500 shares $73,875.00 +4.8%0.3%1.2 $1.97 2/28/202335,800 shares $78,760.00 +96.7%0.3%0.7 $2.20 2/15/202318,200 shares $40,586.00 -56.6%0.1%0.4 $2.23 1/31/202341,900 shares $106,426.00 -4.3%0.3%0.9 $2.54 1/15/202343,800 shares $100,302.00 -15.4%0.4%1 $2.29 12/30/202251,800 shares $108,262.00 -40.6%0.4%1.2 $2.09 12/15/202287,200 shares $149,112.00 +149.1%0.7%2 $1.71 11/30/202235,000 shares $64,750.00 +44.0%0.2%0.8 $1.85 11/15/202224,300 shares $45,684.00 -42.1%0.2%0.5 $1.88 10/31/202242,000 shares $81,900.00 -24.5%0.3%0.7 $1.95 10/15/202255,600 shares $116,204.00 -37.3%0.4%0.9 $2.09 9/30/202288,600 shares $171,884.00 -7.2%0.7%1.4 $1.94 9/15/202295,500 shares $193,865.00 -2.7%0.7%1.6 $2.03 8/31/202298,100 shares $195,219.00 +182.7%0.7%1.4 $1.99“Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. BCDA Short Interest - Frequently Asked Questions What is BioCardia's current short interest? Short interest is the volume of BioCardia shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 271,200 shares of BCDA short. Learn More on BioCardia's current short interest. What is a good short interest ratio for BioCardia? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCDA shares currently have a short interest ratio of 1.0. Learn More on BioCardia's short interest ratio. Which institutional investors are shorting BioCardia? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioCardia: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is BioCardia's short interest increasing or decreasing? BioCardia saw a decrease in short interest in April. As of April 15th, there was short interest totaling 271,200 shares, a decrease of 49.4% from the previous total of 535,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioCardia's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to BioCardia: Genetic Technologies Limited (0.36%), Organovo Holdings, Inc. (1.49%), Coeptis Therapeutics Holdings, Inc. (0.66%), Palisade Bio, Inc. (4.12%), Creative Medical Technology Holdings, Inc. (1.76%), Titan Pharmaceuticals, Inc. (1.72%), Fresh Tracks Therapeutics, Inc. (0.17%), TRACON Pharmaceuticals, Inc. (1.16%), Finch Therapeutics Group, Inc. (1.96%), Avalon GloboCare Corp. (2.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short BioCardia stock? Short selling BCDA is an investing strategy that aims to generate trading profit from BioCardia as its price is falling. BCDA shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioCardia? A short squeeze for BioCardia occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCDA, which in turn drives the price of the stock up even further. How often is BioCardia's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCDA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Genetic Technologies Short Interest Organovo Short Interest Coeptis Therapeutics Short Interest Palisade Bio Short Interest Creative Medical Technology Short Interest Titan Pharmaceuticals Short Interest Fresh Tracks Therapeutics Short Interest TRACON Pharmaceuticals Short Interest Finch Therapeutics Group Short Interest Avalon GloboCare Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCDA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press